Tuyet Nguyen, APRN
Psychiatric/Mental Health · Nashua, NHNPI 1295159465
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. AbbVie accounts for 61.2% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $934, 4.6 times the $205 reported in 2021.
Across 85 payments — averaging $26.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Axsome Therapeutics, Inc.$372
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$366
- Takeda Pharmaceuticals U.S.A., Inc.$113
- Bayer$14
What the payments were for
- Food & beverage$2,18298%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $1,364 |
| Axsome Therapeutics, Inc. | 8 | $372 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $366 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,229 in reported general payments places this provider in the 85th percentile of 264 psychiatric/mental health providers in New Hampshire.
See all psychiatric/mental health providers in New Hampshire →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $1,479 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $952 |
| Aripiprazole | 19 | $497 |
| Buspirone Hcl | 32 | $446 |
| Sertraline Hcl | 18 | $354 |
| Bupropion XlBupropion Hcl | 27 | $327 |
| Fluoxetine Hcl | 24 | $156 |
| Mirtazapine | 13 | $138 |
| Alprazolam | 16 | $92 |
| Lorazepam | 28 | $79 |
| Trazodone Hcl | 24 | $40 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Nashua
- Chengping WangNashua$11K
- Katherine BrockNashua$3K
- Susan VonderheideNashua$3K
- Yara HenningerNashua$3K
- Mertie PotterNashua$3K
- Jennifer PennNashua$2K
- Christine IsabelleNashua$2K
- Christina FarnworthNashua$2K
- Jane McGrathNashua$2K
- Despina O'DohertyNashua$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.